BNP Paribas Financial Markets
KYMR icon

BNP Paribas Financial Markets’s Kymera Therapeutics KYMR Stock Holding History

BNP Paribas Financial Markets’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1M Buy
375,868
+89,997
+31% +$7.73M 0.01% 841
2026
Q1 		$23.8M Buy
285,871
+277,073
+3,149% +$21.9M 0.01% 1039
2025
Q4 		$685K Sell
8,798
-1,849
-17% -$125K ﹤0.01% 3385
2025
Q3 		$603K Buy
10,647
+5,665
+114% +$255K ﹤0.01% 3447
2025
Q2 		$217K Buy
4,982
+1,565
+46% +$53.9K ﹤0.01% 3745
2025
Q1 		$93.5K Sell
3,417
-6,421
-65% -$234K ﹤0.01% 4058
2024
Q4 		$396K Buy
+9,838
New +$444K ﹤0.01% 3436
2022
Q4 		– Sell
-75,804
Closed -$1.65M – 4343
2022
Q3 		$1.65M Buy
+75,804
New +$2M ﹤0.01% 2101

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BNP Paribas Financial Markets's KYMR Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Kymera Therapeutics (KYMR) stake by 31% in Q2 2026, buying an estimated $7.73M and bringing the position to 375,868 shares worth $43.1M. The position accounts for 0.01% of the portfolio, ranked #841.

BNP Paribas Financial Markets first reported a position in KYMR in Q3 2022 and has held it in 8 quarters since. 255 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • BNP Paribas Financial Markets held 375,868 shares of Kymera Therapeutics worth $43.1M as of Q2 2026.
  • BNP Paribas Financial Markets bought 89,997 Kymera Therapeutics shares in Q2 2026, an estimated $7.73M.
  • Kymera Therapeutics made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #841 holding.
  • BNP Paribas Financial Markets first reported a position in Kymera Therapeutics in Q3 2022 and has held it in 8 quarters since.
  • 255 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.